Keck School Faculty

Jubin Joseph

Jubin Joseph

Clinical Assistant Professor of Medicine (Clinician Educator)
Medicine
1520 San Pablo St. Health Sciences Campus Los Angeles

The Peel Foundation: The Peel and Rothwell Jackson Postgraduate Fellowship, 2020-2021

Royal Berkshire Hospital, Reading: Chairman's Prize, 2015-2015

European Society of Cardiology: Cardiologist of Tomorrow, 2014-2017

Southdown Trust : Medical Education Travel Award, 2008-2008

Royal College of Surgeons, London: Preiskel Prize, 2008-2008

Nichol Young Foundation Scholarship: Medical Education Travel Award, 2008-2008

Cambridge University: Preparing for Patients Prize, 2003-2003

Two-year outcomes from the MitrAl ValvE RepaIr Clinical (MAVERIC) trial: a novel percutaneous treatment of functional mitral regurgitation Eur J Heart Fail. 2021 10; 23(10):1775-1783. . View in PubMed

Safety and Operational Efficiency of Restructuring and Redeploying a Transcatheter Aortic Valve Replacement Service During the COVID-19 Pandemic: The Oxford Experience Cardiovasc Revasc Med. 2021 10; 31:26-31. . View in PubMed

Physiological Impact of Afterload Reduction on Cardiac Mechanics and Coronary Hemodynamics Following Isosorbide Dinitrate Administration in Ischemic Heart Disease J Cardiovasc Transl Res. 2021 10; 14(5):962-974. . View in PubMed

Impact of coronary artery disease on contractile function and ventricular-arterial coupling during exercise: Simultaneous assessment of left-ventricular pressure-volume and coronary pressure and flow during cardiac catheterization Physiol Rep. 2021 05; 9(10):e14768. . View in PubMed

Usefulness of Computed Tomography to Predict Mitral Stenosis After Transcatheter Mitral Valve Edge-to-Edge Repair Am J Cardiol. 2021 08 15; 153:109-118. . View in PubMed

Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis Hospitalized With Acute Heart Failure Am J Cardiol. 2021 04 01; 144:100-110. . View in PubMed

Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience JACC Cardiovasc Interv. 2021 01 25; 14(2):172-181. . View in PubMed

Percutaneous Edge-to-Edge Mitral Valve Repair With the MitraClip System Following Surgical Annuloplasty Ring Dehiscence JACC Cardiovasc Interv. 2021 06 14; 14(11):1267-1269. . View in PubMed

Baseline NT-proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation J Am Heart Assoc. 2020 12; 9(23):e017574. . View in PubMed

Women in Cardiology: The British Junior Cardiologists' Association identifies challenges Eur Heart J. 2019 01 14; 40(3):227-231. . View in PubMed

Impact of Complications During Transfemoral Transcatheter Aortic Valve Replacement: How Can They Be Avoided and Managed? J Am Heart Assoc. 2019 09 17; 8(18):e013801.. View in PubMed

Guidelines in review: Comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary artery disease J Nucl Cardiol. 2018 04; 25(2):509-515. . View in PubMed

CXCR2 Inhibition - a novel approach to treating CoronAry heart DiseAse (CICADA): study protocol for a randomised controlled trial Trials. 2017 Oct 11; 18(1):473. . View in PubMed

The big parade: emerging percutaneous mitral and tricuspid valve devices EuroIntervention. 2017 Sep 24; 13(AA):AA51-AA59. . View in PubMed

Young Investigators Prize finalists at the British Cardiovascular Society annual conference 2017 Heart. 2017 10; 103(20):1647-1649. . View in PubMed

A Randomised tRial of Expedited transfer to a cardiac arrest centre for non-ST elevation ventricular fibrillation out-of-hospital cardiac arrest: The ARREST pilot randomised trial Resuscitation. 2017 06; 115:185-191. . View in PubMed

Timing of coronary angioplasty in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J Qual Care Clin Outcomes. 2017 01 01; 3(1):6-8. . View in PubMed

Primary Angioplasty For Patients in Cardiogenic Shock: Optimal Management Interv Cardiol. 2016 May; 11(1):39-43. . View in PubMed

A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial) Eur Heart J Cardiovasc Imaging. 2015 Aug; 16(8):834-41. . View in PubMed

Steerable sheath technology in the ablation of atrial fibrillation Recent Pat Cardiovasc Drug Discov. 2013 Dec; 8(3):171-7. . View in PubMed

Prioritizing echocardiography in Staphylococcus aureus bacteraemia J Antimicrob Chemother. 2013 Feb; 68(2):444-9. . View in PubMed

Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death Heart. 2012 Jan; 98(1):48-53. . View in PubMed

Dr Jubin P. Joseph, MD PhD is the Associate Director of Structural Interventions in the Cardiac & Vascular Institute and Clinical Assistant Professor of Medicine at the Keck School of Medicine of the University of Southern California.

Dr Joseph graduated from Cambridge University in 2005 and completed his medical education at Oxford University in 2008. He completed internal medicine and cardiology training in prestigious programs in England. He was awarded a competitive clinical research fellowship grant to undertake invasive physiology research which he performed at St Thomas’ Hospital in London, UK which resulted in the award of a PhD whilst also learning interventional cardiology under the guidance of Prof Simon Redwood. He then completed a two-year advanced interventional and structural fellowship at Oxford University Hospitals in Oxford, England under the leadership of Prof Adrian Banning. Following this, he was recruited to Cedars Sinai Medical Center in Los Angeles, California in 2020 where he underwent further advanced training in structural heart interventions – performing a large number of transcatheter aortic, mitral and tricuspid valve replacements and repairs with both commercially available and emerging research devices, before joining Keck Medical Center of USC in 2022.

Dr Joseph is an Interventional Cardiologist with specialized clinical and research interests in structural heart disease, particularly transcatheter valve therapy. He has a large volume of expertise in transcatheter aortic, mitral and tricuspid replacement, percutaneous mitral valve repair, left atrial appendage occlusion, PFO/ASD/VSD closure, paravalvular leak closure, alcohol septal ablation and cerebral protection. He is a clinical investigator in ongoing national multi-center research studies and clinical trials and has co-authored numerous peer reviewed, scientific articles and book chapters. He has research interests in cardiovascular physiology, microvascular dysfunction, structural heart disease and emerging transcatheter therapy devices. Dr Joseph speaks regularly at major national and international cardiology meetings.
sc ctsi logoPowered by SC CTSI